Literature DB >> 29435515

The Smyd Family of Methyltransferases: Role in Cardiac and Skeletal Muscle Physiology and Pathology.

Christopher Tracy1, Junco S Warren1, Marta Szulik1, Li Wang1, June Garcia1, Aman Makaju1, Kristi Russell1, Mickey Miller1, Sarah Franklin1.   

Abstract

Protein methylation plays a pivotal role in the regulation of various cellular processes including chromatin remodeling and gene expression. SET and MYND domain-containing proteins (Smyd) are a special class of lysine methyltransferases whose catalytic SET domain is split by an MYND domain. The hallmark feature of this family was thought to be the methylation of histone H3 (on lysine 4). However, several studies suggest that the role of the Smyd family is dynamic, targeting unique histone residues associated with both transcriptional activation and repression. Smyd proteins also methylate several non-histone proteins to regulate various cellular processes. Although we are only beginning to understand their specific molecular functions and role in chromatin remodeling, recent studies have advanced our understanding of this relatively uncharacterized family, highlighting their involvement in development, cell growth and differentiation and during disease in various animal models. This review summarizes our current knowledge of the structure, function and methylation targets of the Smyd family and provides a compilation of data emphasizing their prominent role in cardiac and skeletal muscle physiology and pathology.

Entities:  

Keywords:  Smyd; Smyd1; Smyd2; Smyd3; Smyd4; Smyd5; epigenetics; heart; histone methyltransferase

Year:  2017        PMID: 29435515      PMCID: PMC5807017          DOI: 10.1016/j.cophys.2017.10.001

Source DB:  PubMed          Journal:  Curr Opin Physiol        ISSN: 2468-8673


  76 in total

1.  skNAC, a Smyd1-interacting transcription factor, is involved in cardiac development and skeletal muscle growth and regeneration.

Authors:  Chong Yon Park; Stephanie A Pierce; Morgan von Drehle; Kathryn N Ivey; Jayson A Morgan; Helen M Blau; Deepak Srivastava
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-11       Impact factor: 11.205

2.  SMYD3 as an oncogenic driver in prostate cancer by stimulation of androgen receptor transcription.

Authors:  Cheng Liu; Chang Wang; Kun Wang; Li Liu; Qi Shen; Keqiang Yan; Xiaoqing Sun; Jie Chen; Jikai Liu; Hongbo Ren; Hainan Liu; Zhonghua Xu; Sanyuan Hu; Dawei Xu; Yidong Fan
Journal:  J Natl Cancer Inst       Date:  2013-10-30       Impact factor: 13.506

Review 3.  SMYD proteins: key regulators in skeletal and cardiac muscle development and function.

Authors:  Shao Jun Du; Xungang Tan; Jianshe Zhang
Journal:  Anat Rec (Hoboken)       Date:  2014-09       Impact factor: 2.064

4.  An Integrative Proteomic Approach Identifies Novel Cellular SMYD2 Substrates.

Authors:  Hazem Ahmed; Shili Duan; Cheryl H Arrowsmith; Dalia Barsyte-Lovejoy; Matthieu Schapira
Journal:  J Proteome Res       Date:  2016-05-10       Impact factor: 4.466

5.  skNAC and Smyd1 in transcriptional control.

Authors:  Janine Berkholz; Mickael Orgeur; Sigmar Stricker; Barbara Munz
Journal:  Exp Cell Res       Date:  2015-07-07       Impact factor: 3.905

6.  SmyD1, a histone methyltransferase, is required for myofibril organization and muscle contraction in zebrafish embryos.

Authors:  Xungang Tan; Josep Rotllant; Huiqing Li; Patrick De Deyne; Patrick DeDeyne; Shao Jun Du
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

7.  Serum response factor orchestrates nascent sarcomerogenesis and silences the biomineralization gene program in the heart.

Authors:  Zhiyv Niu; Dinakar Iyer; Simon J Conway; James F Martin; Kathryn Ivey; Deepak Srivastava; Alfred Nordheim; Robert J Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-12       Impact factor: 11.205

8.  Crystal structures of histone and p53 methyltransferase SmyD2 reveal a conformational flexibility of the autoinhibitory C-terminal domain.

Authors:  Yuanyuan Jiang; Nualpun Sirinupong; Joseph Brunzelle; Zhe Yang
Journal:  PLoS One       Date:  2011-06-28       Impact factor: 3.240

9.  Identification and characterization of Smyd2: a split SET/MYND domain-containing histone H3 lysine 36-specific methyltransferase that interacts with the Sin3 histone deacetylase complex.

Authors:  Mark A Brown; Robert J Sims; Paul D Gottlieb; Philip W Tucker
Journal:  Mol Cancer       Date:  2006-06-28       Impact factor: 27.401

10.  SMYD1, the myogenic activator, is a direct target of serum response factor and myogenin.

Authors:  Dali Li; Zhiyv Niu; Weishi Yu; Yu Qian; Qian Wang; Qiang Li; Zhengfang Yi; Jian Luo; Xiushan Wu; Yuequn Wang; Robert J Schwartz; Mingyao Liu
Journal:  Nucleic Acids Res       Date:  2009-11       Impact factor: 16.971

View more
  26 in total

1.  Histone methyltransferase Smyd1 regulates mitochondrial energetics in the heart.

Authors:  Junco S Warren; Christopher M Tracy; Mickey R Miller; Aman Makaju; Marta W Szulik; Shin-Ichi Oka; Tatiana N Yuzyuk; James E Cox; Anil Kumar; Bucky K Lozier; Li Wang; June García Llana; Amira D Sabry; Keiko M Cawley; Dane W Barton; Yong Hwan Han; Sihem Boudina; Oliver Fiehn; Haley O Tucker; Alexey V Zaitsev; Sarah Franklin
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-30       Impact factor: 11.205

2.  Function of the MYND Domain and C-Terminal Region in Regulating the Subcellular Localization and Catalytic Activity of the SMYD Family Lysine Methyltransferase Set5.

Authors:  Deepika Jaiswal; Rashi Turniansky; James J Moresco; Sabeen Ikram; Ganesh Ramaprasad; Assefa Akinwole; Julie Wolf; John R Yates; Erin M Green
Journal:  Mol Cell Biol       Date:  2020-01-03       Impact factor: 4.272

3.  Perm1 regulates cardiac energetics as a downstream target of the histone methyltransferase Smyd1.

Authors:  Shin-Ichi Oka; Amira D Sabry; Amanda K Horiuchi; Keiko M Cawley; Sean A O'Very; Maria A Zaitsev; Thirupura S Shankar; Jaemin Byun; Risa Mukai; Xiaoyong Xu; Natalia S Torres; Anil Kumar; Masayuki Yazawa; Jing Ling; Iosif Taleb; Yukio Saijoh; Stavros G Drakos; Junichi Sadoshima; Junco S Warren
Journal:  PLoS One       Date:  2020-06-23       Impact factor: 3.240

4.  Crystallographic and Computational Characterization of Methyl Tetrel Bonding in S-Adenosylmethionine-Dependent Methyltransferases.

Authors:  Raymond C Trievel; Steve Scheiner
Journal:  Molecules       Date:  2018-11-13       Impact factor: 4.411

5.  Overexpression of SET and MYND Domain-Containing Protein 2 (SMYD2) Is Associated with Tumor Progression and Poor Prognosis in Patients with Papillary Thyroid Carcinoma.

Authors:  Wenchao Xu; Fulian Chen; Xiao Fei; Xiaoqing Yang; Xiaofei Lu
Journal:  Med Sci Monit       Date:  2018-10-15

6.  The Lysine Methylase SMYD3 Modulates Mesendodermal Commitment during Development.

Authors:  Raffaella Fittipaldi; Pamela Floris; Valentina Proserpio; Franco Cotelli; Monica Beltrame; Giuseppina Caretti
Journal:  Cells       Date:  2021-05-18       Impact factor: 6.600

7.  Transcriptomic Profiling of Skeletal Muscle Reveals Candidate Genes Influencing Muscle Growth and Associated Lipid Composition in Portuguese Local Pig Breeds.

Authors:  André Albuquerque; Cristina Óvilo; Yolanda Núñez; Rita Benítez; Adrián López-Garcia; Fabián García; Maria do Rosário Félix; Marta Laranjo; Rui Charneca; José Manuel Martins
Journal:  Animals (Basel)       Date:  2021-05-16       Impact factor: 2.752

8.  Critical roles of SMYD2 lysine methyltransferase in mediating renal fibroblast activation and kidney fibrosis.

Authors:  Lirong Liu; Feng Liu; Yingjie Guan; Jianan Zou; Chunyun Zhang; Chongxiang Xiong; Ting C Zhao; George Bayliss; Xiaogang Li; Shougang Zhuang
Journal:  FASEB J       Date:  2021-07       Impact factor: 5.834

Review 9.  Histone methyltransferase SMYD2: ubiquitous regulator of disease.

Authors:  Xin Yi; Xue-Jun Jiang; Ze-Min Fang
Journal:  Clin Epigenetics       Date:  2019-08-01       Impact factor: 6.551

10.  The SMYD3 methyltransferase promotes myogenesis by activating the myogenin regulatory network.

Authors:  Roberta Codato; Martine Perichon; Arnaud Divol; Ella Fung; Athanassia Sotiropoulos; Anne Bigot; Jonathan B Weitzman; Souhila Medjkane
Journal:  Sci Rep       Date:  2019-11-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.